The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...

A company that makes baby food for Target is recalling more than 25,000 packages of a product because it may contain elevated ...